Raia Drogasil SA (OTCPK:RADLY)
$ 4.02 0.28 (7.49%) Market Cap: 6.90 Bil Enterprise Value: 7.62 Bil PE Ratio: 36.22 PB Ratio: 7.05 GF Score: 85/100

Q2 2024 Raia Drogasil S/A Earnings Call Transcript

Aug 07, 2024 / 01:00PM GMT
Release Date Price: $5.1 (-5.03%)
Operator

This presentation will be available on RD Saude investor relations website at ir.rdsaude.com.br where the audio for this conference also will be posted later. Later, we will begin the question-and-answer session.

Before proceeding, let me mention that forward-looking statements are being made under the Safe Harbor of the Securities Litigation Reform Act of 1996. Forward-looking statements are based on the beliefs and assumptions of RD Saude's management and on information currently available to the company. Forward-looking statements are not guarantees of performance. They involve risks, uncertainties and assumptions because they relate to future events, and therefore, depend on circumstances that may or may not occur in the future. Our investors should understand that general economic conditions, industry conditions and other operating factors could also affect the future results of RD Saude and also could cause results to differ materially from those expressed in such forward-looking statements.

Today, joining us from RD Saude studio are Mr. Marcilio Pousada, CEO; and Mr. Flavio de

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot